Tag: Applications

  • Over-The-Counter (OTC) Products-Eye Care Market Projected at $48.08 Billion by 2029 | Strategic Insights and Forecast Data

    Over-The-Counter (OTC) Products-Eye Care Market Projected at $48.08 Billion by 2029 | Strategic Insights and Forecast Data

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Over-The-Counter (OTC) Products-Eye Care Market Size Changed, over the years?

    The market size for over-the-counter (OTC) products, specifically in eye care, has shown significant growth in the recent past. Projected growth rate indicates that the market will escalate from $31.17 billion in 2024 to reach a value of $34.08 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The notable expansion during the historical period can be tied back to factors such as the rise in digital eye strain, increase in the older population worldwide, growing understanding about the significance of maintaining eye health and cleanliness, the rise in self-medication patterns, and amplified availability of OTC products through both retail and e-commerce platforms.

    How Much Will the Over-The-Counter (OTC) Products-Eye Care Market Be Worth in 2029?

    The market size of over-the-counter (OTC) eye care products is predicted to experience substantial growth in the coming years, with a projection to reach $48.08 billion in 2029, escalating at a compound annual growth rate (CAGR) of 9.0%. This projected growth during the forecast period may be attributed to factors such as rising urban pollution and allergens, an increasing prevalence of lifestyle-related eye diseases, the surge in preventive eye care adoption, product innovation and marketing efforts by the main industry players, as well as growing demand in developing economies. Key trends to watch during the forecast period include progress in preservative-free formulations, assimilation of digital health tools with eye care products, technology-driven packaging innovations, progress in nanotechnology-based eye care remedies, and advancements in artificial tear and lubricant formulations.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24643&type=smp

    Which is the Largest Company in the Over-The-Counter (OTC) Products-Eye Care Market?

    Major companies operating in the over-the-counter (OTC) products-eye care market are AbbVie, Novartis AG, Alcon, Intas Pharmaceuticals, Macleods Pharmaceuticals, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Bausch + Lomb, Dr. Reddy’s Laboratories, Cipla Ltd., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical, GlenMark Pharmaceuticals Ltd., Ocusoft Inc., Medicom Healthcare, NovaBay Pharmaceuticals Inc., Himalaya Wellness Company, Grevis Pharmaceuticals, TearRestore Inc., Théa Pharma Inc.

    What Are the Main Market Drivers in the Over-The-Counter (OTC) Products-Eye Care Industry?

    The growth of the over-the-counter (OTC) products-eye care market is projected to go ahead due to increased exposure to digital screens. The term ‘digital screen exposure’ refers to the time spent looking at screens on devices such as tablets, smartphones, and computers, which has been on the rise due to the necessity of remote work and digital communication causing the daily use of screens to extend. OTC eye care products alleviate the effects of digital screen exposure by easing dryness, lessening irritation, and preserving eye hydration, all resulting from extended screen time. To illustrate, the Centers for Disease Control and Prevention, a US governmental agency, indicated in October 2024 that more than half of all teenagers aged 12–17 (50.4%) spent at least 4 hours each day on screens between July 2021 and December 2023. Additionally, 22.8% averaged 3 hours, 17.8% spent 2 hours, 6.1% employed 1 hour, and a mere 3.0% used screens for less than an hour a day. As a result, the increasing exposure to digital screens is fuelling the over-the-counter (OTC) products-eye care market expansion.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24643&type=smp

    How Is the Over-The-Counter (OTC) Products-Eye Care Market Segments Structured?

    The over-the-counter (OTC) products-eye care market covered in this report is segmented –

    1) By Product: Contact Lenses, Intraocular Lenses, Ocular Health Products, Other Products

    2) By Distribution Channel: Hospitals And Clinics, Retail Stores, Online Stores, Other Distribution Channels

    3) By Application: Dry Eye Treatment, Allergy Relief, Infection Prevention And Treatment, Vision Support, Post-Procedure Eye Comfort

    Subsegments:

    1) By Contact Lenses: Soft Contact Lenses, Rigid Gas Permeable (RGP) Lenses, Hybrid Contact Lenses, Daily Disposable Lenses, Extended Wear Lenses, Cosmetic (Colored) Lenses

    2) By Intraocular Lenses: Monofocal Intraocular Lenses, Multifocal Intraocular Lenses, Toric Intraocular Lenses, Accommodative Intraocular Lenses, Phakic Intraocular Lenses

    3) By Ocular Health Products: Artificial Tears And Lubricants, Antihistamine Eye Drops, Redness Relievers, Antibiotic Eye Drops, Eye Wash Solutions, Nutritional Supplements

    4) By Other Products: Eye Patches And Shields, Eye Compresses, Eyelid Cleansers And Wipes, Blue Light Blocking Glasses, Eye Vitamins And Herbal Remedies, Vision Therapy Tools

    What Strategic Trends Are Transforming the Over-The-Counter (OTC) Products-Eye Care Market?

    Predominant corporations in the over-the-counter (OTC) products-eye care market are prioritizing the development of innovative items such as OTC eye drops, intended to improve moisture preservation and provide enduring relief from usual eye discomforts. These non-prescription solutions usually address eye problems like dryness, redness, irritation, and allergies, offering immediate comfort by lubricating the eye and stimulating overall eye wellbeing. To illustrate, in August 2024, Glenmark Pharmaceuticals, a renowned pharmaceutical firm based in the US, introduced Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), into the American market. The product’s design caters to the escalating demand for allergy eye drops, making it a viable competitor to Pataday Twice Daily Relief. It is available in significant retail shops and pharmacies in the US, bolstering Glenmark’s consumer healthcare portfolio.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-products-eye-care-global-market-report

    Which Global Regions Offer the Highest Growth in the Over-The-Counter (OTC) Products-Eye Care Market?

    North America was the largest region in the over-the-counter (OTC) products-eye care market in 2024. The regions covered in the over-the-counter (OTC) products-eye care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24643

    This Report Delivers Insight On:

    1. How big is the over-the-counter (otc) products-eye care market, and how is it changing globally?

    2. Who are the major companies in the over-the-counter (otc) products-eye care market, and how are they performing?

    3. What are the key opportunities and risks in the over-the-counter (otc) products-eye care market right now?

    4. Which products or customer segments are growing the most in the over-the-counter (otc) products-eye care market?

    5. What factors are helping or slowing down the growth of the over-the-counter (otc) products-eye care market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Market Analysis on Neglected Tropical Disease Treatment Industry – Insights for Corporate Strategy and R&D

    Market Analysis on Neglected Tropical Disease Treatment Industry – Insights for Corporate Strategy and R&D

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #What Is the Forecast for the Neglected Tropical Disease Treatment Market from 2024 to 2025?#_x000D_

    The market size for treatment of neglected tropical diseases has seen robust growth in the past few years. The market, which was worth $3.36 billion in 2024, is projected to increase to $3.57 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.3%. The notable progression in the historical period is due to factors such as increased governmental emphasis on disease eradication efforts, growing collaborations between private and public entities for drug donations, escalated drug donations from international pharmaceutical manufacturers, expanded research into cost-effective antiparasitic therapies, and heightened investments in the development of vaccines and diagnostics._x000D_

    _x000D_

    #What Is the Projected Market Size of the Neglected Tropical Disease Treatment Market?#_x000D_

    In the forthcoming years, the market size of the neglected tropical disease treatment is predicted to witness robust growth, reaching $4.52 billion by the year 2029, with a compound annual growth rate (CAGR) of 6.1%. The forecast period’s expansion is due to factors like the increasing use of digital methods for disease monitoring, a burgeoning pipeline of novel therapies and vaccines, heightened urgency to tackle antimicrobial resistance, enhanced international cooperation for disease eradication, and increasing spread of diseases due to climate change. The forthcoming period’s prominent trends encompass the development of localized treatment strategies, low-cost vaccine platforms, consolidation with fundamental healthcare systems, amalgamation of disease monitoring networks, and innovation in vector control solutions._x000D_

    _x000D_

    #Download The Free Sample Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp_x000D_

    _x000D_

    #Who are the Major Competitors in the Neglected Tropical Disease Treatment Market Outlook?#_x000D_

    Major companies operating in the neglected tropical disease treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Eisai Co. Ltd., Shionogi And Co. Ltd., Dr. Reddy`s Laboratories Ltd, Cipla Ltd., Eiken Chemical Company Ltd, LifeArc, Atomwise Inc., Medicines Development for Global Health Ltd._x000D_

    _x000D_

    #What Is Fueling Growth in the Neglected Tropical Disease Treatment Market?#_x000D_

    The increasing incidence of infectious illnesses is anticipated to drive the expansion of the neglected tropical disease treatment market in the future. Infections are caused by harmful microscopic organisms such as bacteria, viruses, fungi or parasites and can be transmitted either directly or indirectly between individuals. This increasing prevalence is largely attributed to enhanced travel, which enables quick transmission of pathogens across borders. Neglected tropical disease treatments address these infectious diseases by offering specific therapies that curb and eradicate the dispersal of diseases. These interventions enhance public health results, notably in susceptible communities, by minimizing the disease burden and preventing chronic disabilities. For instance, the UK Health Security Agency, a government organization based in the UK, reported in February 2024 that tuberculosis cases in England had increased to 4,850 in 2023, a surge of 10.7% from 4,380 cases the previous year in 2022. Hence, the increasing prevalence of infectious diseases is contributing towards the growth of the neglected tropical disease treatment market._x000D_

    _x000D_

    #Request For A Customized Report:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=24616&type=smp_x000D_

    _x000D_

    #Which Neglected Tropical Disease Treatment Market Segments Are Growing the Fastest?#_x000D_

    The neglected tropical disease treatment market covered in this report is segmented –_x000D_

    _x000D_

    1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class_x000D_

    2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types_x000D_

    3) By Route of Administration: Oral, Parenteral_x000D_

    4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_

    5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides_x000D_

    2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins_x000D_

    3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides_x000D_

    4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments_x000D_

    _x000D_

    #Which Industry Trends Are Shaping the Future of the Neglected Tropical Disease Treatment Market?#_x000D_

    Leading corporations involved in the neglected tropical disease treatment market are making strategic investments to boost their research and development capabilities, gain global reach, and enhance the efficacy of their innovative treatments. Such investments are fueling the growth of this market as they support advanced research, cultivate partnerships, and speed up the creation of affordable and impactful treatments for disadvantaged communities. For example, in June 2022, Novartis AG, a pharmaceutical firm based in Switzerland, invested $250 million towards combating neglected tropical diseases (NTDs) and malaria. This significant investment is intended to increase the availability of treatments in low-income areas and further the development of new therapies for neglected tropical diseases._x000D_

    _x000D_

    #Access The Full Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report_x000D_

    _x000D_

    #Which Countries Are Leading the Neglected Tropical Disease Treatment Market?#_x000D_

    Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2024. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

    _x000D_

    #Purchase The Full Report Today:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24616_x000D_

    _x000D_

    #This Report Delivers Insight On: #_x000D_

    1. How big is the neglected tropical disease treatment market, and how is it changing globally?_x000D_

    2. Who are the major companies in the neglected tropical disease treatment market, and how are they performing?_x000D_

    3. What are the key opportunities and risks in the neglected tropical disease treatment market right now?_x000D_

    4. Which products or customer segments are growing the most in the neglected tropical disease treatment market?_x000D_

    5. What factors are helping or slowing down the growth of the neglected tropical disease treatment market?_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 3156230293_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 2071930708_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Celiac Disease Market Trends Report 2025 – For Business Development and Strategy Teams

    Celiac Disease Market Trends Report 2025 – For Business Development and Strategy Teams

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Celiac Disease Market Growth in 2025?

    In the last few years, the market size for celiac disease has seen significant expansion. It is projected to accelerate from $0.71 billion in 2024 to $0.78 billion in 2025, marking a compound annual growth rate (CAGR) of 10.4%. This growth during the historical period is due to several factors, including a surge in celiac disease incidences, heightened knowledge about disorders linked to gluten, more funding allocated for autoimmune diseases research, the rise in food allergy cases and sensitivities, and an increased focus on health among consumers.

    What Is the Forecast for the Celiac Disease Market Size Through 2029?

    The market for celiac disease is set for swift expansion in the upcoming years, with projections suggesting it will surge to $1.15 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this predicted growth in the forecast period are the escalating demand for personalized medicine, strengthened healthcare facilities, increased needs for dietetic counseling services, and higher rates of pediatric diagnosis. Other proactive steps towards early detection and prevention are also key contributors. Noteworthy trends for the forecast period comprise the accessibility of diagnostic tests, advancements in the field of genetic testing, enhanced primary care screening protocols, cutting-edge innovations in ELISA and serological testing, and the embrace of non-evasive diagnostic methodologies.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp

    What are the Key Market Players in Celiac Disease Market and How They’re Evolving?

    Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

    What Are the Primary Growth Drivers in the Celiac Disease Market?

    The expansion of the celiac disease market is anticipated to be propelled by the rise in personalized medicine. Personalized healthcare, which individualizes medical treatment based on one’s genetic makeup, environment, and lifestyle, is at the heart of this. The surge in genetic testing availability, which makes for more precise diagnoses and treatments tailored to each patient, is heightening the appeal of personalized medicine. It aids in the treatment of celiac disease by facilitating the exact identification of genetic markers and personal immune responses, resulting in more specific and effective management techniques for each patient. For example, the US-based nonprofit organization, the Personalized Medicine Coalition, reported in February 2024 that the FDA sanctioned 16 personalized therapies aimed at rare diseases in 2023, an increase from the 6 that were approved in 2022. Therefore, the rise in personalized medicine is set to stimulate the expansion of the celiac disease market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24497&type=smp

    What Are the Leading Segments in the Global Celiac Disease Industry?

    The celiac disease market covered in this report is segmented –

    1) By Treatment: Infliximab, Larazotide Acetate, Gluten Free Diet, Other Treatments

    2) By Route Of Administration: Oral, Parenteral

    3) By End Users: Hospitals, Homecare, Other End-Users

    Subsegments:

    1) By Infliximab: Biosimilar Infliximab, Branded Infliximab, Intravenous Administration, Hospital-Based Usage, Off-Label Use In Refractory Celiac Disease,

    2) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

    3) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

    4) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

    What Are the Key Market Trends in the Celiac Disease Industry?

    Leading corporations in the celiac disease sector are making strides in producing sophisticated solutions like anti-interleukin-15 (IL-15) antibodies, designed to prevent tissue harm by curbing the heightened activity of the immune cells. These antibodies are specialized proteins that hinder the IL-15 cytokine’s functionality, thereby keeping a check on the immune activity and inflammation. Notably, in May 2025, Teva Pharmaceutical Industries, a pharmaceutical firm based in Israel, reported that the U.S. Food and Drug Administration had allocated Fast Track status to its under-investigation anti-IL-15 antibody, TEV-53408. This investigational monoclonal antibody, targeted for individuals suffering from celiac disease who persist with a gluten-free diet, acts by obstructing IL-15, an element instrumental in igniting the immune response consequential in intestinal damage in sufferers of celiac disease. Currently, the treatment’s safety and effectiveness are under scrutiny in a Phase 2a clinical trial.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report

    What Is the Regional Outlook for the Celiac Disease Market?

    North America was the largest region in the celiac disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24497

    This Report Delivers Insight On:

    1. How big is the celiac disease market, and how is it changing globally?

    2. Who are the major companies in the celiac disease market, and how are they performing?

    3. What are the key opportunities and risks in the celiac disease market right now?

    4. Which products or customer segments are growing the most in the celiac disease market?

    5. What factors are helping or slowing down the growth of the celiac disease market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model